Skip to main content
Clinical Trials/NCT01936948
NCT01936948CompletedNot Applicable

Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.

White River Junction Veterans Affairs Medical Center2 sites in 1 country928 target enrollmentStarted: April 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
928
Locations
2
Primary Endpoint
Number of Participants With Delayed Bleeding Complications

Study Overview

Brief Summary

The effectiveness of colonoscopy in reducing colorectal cancer mortality relies on the detection and removal of neoplastic polyps. Because the risk of prevalent cancer and of transition to cancer increases with polyp size, effective and safe resection of large polyps is particularly important. Large polyps ≥20mm are removed by so-called endoscopic mucosal resection (EMR) using electrocautery snares. Resection of these large polyps is associated with a risk of severe complications that may require hospitalization and additional interventions. The most common risk is delayed bleeding which is observed in approximately 2-9% of patients. A recent retrospective study suggests that closure of the large mucosal defect after resection may decrease the risk of delayed bleeding. However, significant uncertainty remains about the polypectomy techniques to optimizing resection and minimizing risk. Important aspects that may affect risk include clipping of the mucosal defect and electrocautery setting.

Detailed Description

Aim 1. The primary aim of the study is to compare the rate of delayed bleeding complications in patients undergoing endoscopic resection of large polyps between:

  • A) Closing the mucosal defect after resection (Clip group) and
  • B) Not closing the mucosal defect after resection (No clip group).

Aim 2. The secondary aim of the study is to compare the rate of overall complications in patients undergoing endoscopic resection of large polyps between two cautery settings:

  • A) Low power coagulation and
  • B) Endocut.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 89 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Any patient ≥18 and ≤89 who presents for a colonoscopy and who does not have criteria for exclusion
  • Patients with a ≥20mm non-pedunculated colon polyp

Exclusion Criteria

  • Patients with known (biopsy proven) invasive carcinoma in a potential study polyp
  • Pedunculated polyps (as defined by Paris Classification type Ip or Isp)
  • Patients with ulcerated depressed lesions (as defined by Paris Classification type III)
  • Patients with inflammatory bowel disease
  • Patients who are receiving an emergency colonoscopy
  • Poor general health (ASA class>3)
  • Patients with coagulopathy with an elevated INR ≥1.5, or platelets <50
  • Poor bowel preparation
  • Pregnancy

Outcomes

Primary Outcomes

Number of Participants With Delayed Bleeding Complications

Time Frame: 30 days following a study polyp resection

A bleeding event that occurred within 30 days after completion of the colonoscopy with a study polyp resection and is associated with a decrease in hemoglobin by at least 2gm, hemodynamic instability, presentation to the ED, need for hospitalization, repeat colonoscopy, or other interventions.

Secondary Outcomes

  • The Overall Number of Complications(30 days)
  • Polyp Recurrence Rate(3 months to 5 years)
  • Complete Study Polyp Resection Rate(6 months)
  • The Number of Complications Associated With Clip Use(30 days)

Investigators

Sponsor Class
Fed
Responsible Party
Principal Investigator
Principal Investigator

Dr. Heiko Pohl

Principal Investigator

White River Junction Veterans Affairs Medical Center

Study Sites (2)

Loading locations...

Similar Trials

Safety of Endoscopic Resection of Large... | Clinical Trial